Enlivex Therapeutics Ltd. (ENLV)
Market Closed
23 Apr, 15:25
TASE 
269. 70
ILA 0
0%
- Market Cap
- P/E Ratio
- Div Yield
81,638 Volume
- Eps
269.7 ILA
Previous Close Want to track ENLV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enlivex Therapeutics Ltd. (ENLV) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.89M
Trailing P/E (ttm) 0.03
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.02
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 863.14K
Average volume (90 days) 256.18K
Price summary
52-Week low 213.2
52-Week high 682.9
Beta -
50-Day moving average 8.7
200-Day moving average 243.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 6 Mar 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.53%
Return on equity 2.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 27.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.13
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 193.24%
Book value per share (mrq) 42.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
